glycopyrronium

Glenmark introduces 3-in-1 inhaler therapy for COPD, promising reduction in risk of severe attacks and improvement in lung function

AIRZ-FF is India's first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population Backed by  latest research…

5 years ago

Treatment with Novartis’ Ultibro® Breezhaler® improved cardiac function in COPD patients with lung hyperinflation

 Ultibro® Breezhaler® provided significant improvements in cardiac and lung function in COPD patients with lung hyperinflation, compared to placebo CLAIM…

7 years ago